Provision of Buprenorphine to Pregnant Women by For-Profit Clinics in an Appalachian City.

CONCLUSIONS: The high cost of for-profit clinics is a barrier for patient access to medication-assisted therapy with buprenorphine. Tapering of buprenorphine dosage in pregnant women has penetrated buprenorphine management practice in our community. Further research is needed to determine whether elimination of cost barrier would have a positive effect on the rates of neonatal abstinence syndrome. PMID: 30285261 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/30285261?dopt=Abstract

Source: Southern Medical Journal - October 6, 2018 Category: General Medicine Tags: South Med J Source Type: research